CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 2015—Genologics announced that GenomeDx Biosciences has implemented Genologics’ laboratory information management system, Clarity LIMS, to support whole transcriptome analysis workflows as part of GenomeDx’s mission to address unmet clinical needs in the management of prostate cancer. Headquartered in Vancouver, BC, GenomeDx will use Clarity LIMS in its CLIA-certified lab in San Diego.
GenomeDx will use the cloud-based version of Clarity LIMS to support samples processed using its genomic test, the Decipher Prostate Cancer Classifier, which GenomeDx uses to predict the probability of cancer spread in men after surgery. Built specifically for genomics labs, Clarity LIMS provides end-to-end sample tracking,
Genologics , 250-483-7011